July 13, 2023 02:01 PM EDTUpdated 02:56 PM
R&D
Pharma
Marketing

Pfiz­er clin­i­cal tri­al reg­istry aims to re­cruit one mil­lion peo­ple for re­search

Beth Snyder Bulik

Senior Editor

Pfiz­er is look­ing to en­roll one mil­lion peo­ple for its new clin­i­cal tri­al reg­istry called Pfiz­er­Link. The bio­phar­ma is ad­ver­tis­ing the clin­i­cal tri­al con­nec­tor on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times